Advertisement

Table of Contents

April 18, 2019; 133 (16)

BLOOD COMMENTARIES

  • Storming the Castle with TCP
    Frits van Rhee and Katie Stone
  • Context-specific tumor suppression by PHF6
    Jennifer J. Trowbridge
  • αIIbβ3 changes gears in MKs and platelets
    Naoshi Sugimoto and Koji Eto

SPECIAL REPORT

BLOOD SPOTLIGHT

CLINICAL TRIALS AND OBSERVATIONS

HEMATOPOIESIS AND STEM CELLS

  • PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia
    PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia
    Helen M. McRae, Alexandra L. Garnham, Yifang Hu, Matthew T. Witkowski, Mark A. Corbett, Mathew P. Dixon, Rose E. May, Bilal N. Sheikh, William Chiang, Andrew J. Kueh, Tan A. Nguyen, Kevin Man, Renee Gloury, Brandon J. Aubrey, Antonia Policheni, Ladina Di Rago, Warren S. Alexander, Daniel H. D. Gray, Andreas Strasser, Edwin D. Hawkins, Stephen Wilcox, Jozef Gécz, Axel Kallies, Matthew P. McCormack, Gordon K. Smyth, Anne K. Voss and Tim Thomas

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

  • Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations
    Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations
    Jonas Samuel Jutzi, Titiksha Basu, Maximilian Pellmann, Sandra Kaiser, Doris Steinemann, Mathijs A. Sanders, Adil S. A. Hinai, Annelieke Zeilemaker, Sarolta Bojtine Kovacs, Christoph Koellerer, Jenny Ostendorp, Konrad Aumann, Wei Wang, Emmanuel Raffoux, Bruno Cassinat, Lars Bullinger, Brigitte Schlegelberger, Peter J. M. Valk and Heike Luise Pahl

PLATELETS AND THROMBOPOIESIS

BLOOD WORK

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS